Brightsurf Science News and Current Science News Events

 
Email a Friend Send to a friend
Printer Friendly Print Molecular basis for neurodegeneration in Ataxia telangiectasia

Molecular basis for neurodegeneration in Ataxia telangiectasia

April 15, 2008

An upcoming paper from Dr. David Wassarman (University of Wisconsin School of Medicine and Public Health) in the May 1 issue of G&D lends new insight into the pathogenesis of neurodegeneration in Ataxia telangiectasia.

Ataxia telangiectasia (A-T) is a rare, genetic immunodeficiency disease that affects multiple organ systems and is characterized by neurodegeneration and cancer predisposition. A-T is caused by recessive mutations in the ataxia telangiectasia mutated (ATM) gene.




While existing animal models have established how ATM mutations contribute to genomic instability and cancer susceptibility, Dr. Wassarman's paper reveals how ATM mutations cause neurodegeneration.

The scientists generated a Drosophila model of A-T, in which neurodeneneration occurs in the absence of induced DNA damage - as it does in human A-T patients. Thus, Dr. Wassarman's model most faithfully recapitulates neurodegeneration associated with the human disease.

Using this model, Dr. Wassarman and colleagues determined ATM functions normally to prevent neurons from re-entering the cell cycle.

"At the end of the day, ATM-dependent arrest of cell growth is critical for both neuron function and tumor suppression," explains Dr. Wassarman. Furthermore, he is excited by the findings, as they "point to possible therapeutic potential of CDC25 and other cell cycle inhibitors" to treat A-T as well as other neurodegenerative disorders.

Cold Spring Harbor Laboratory



Related Neurodegeneration News Articles Neurodegeneration News and Current Neurodegeneration Events RSS Neurodegeneration News and Current Neurodegeneration Events RSS
Lou Gehrig's protein found throughout brain, suggesting effects beyond motor neurons
Two years ago researchers at the University of Pennsylvania School of Medicine discovered that misfolded proteins called TDP-43 accumulated in the motor areas of the brains of patients with amyotropic lateral sclerosis (ALS), or Lou Gehrig's disease.

Genetics of ALS progression
An upcoming paper from Drs. Hidenori Ichijo and Hideki Nishitoh (The University of Tokyo) and colleagues lends new and valuable insight into the genetics of ALS.

'Intrabody' can mop up mutant protein in Huntington's disease model
Scientists have created a tool for mopping up the clumps of mutant protein that drive neurodegeneration in Huntington's disease. Emory University researchers engineered a virus to make an intracellular antibody or "intrabody" against huntingtin, the protein whose mutant forms poison the brain cells of people with Huntington's.

RNA Toxicity Contributes to Neurodegenerative Disease, University of Pennsylvania Scientists Say
Expanding on prior research performed at the University of Pennsylvania, Penn biologists have determined that faulty RNA, the blueprint that creates mutated, toxic proteins, contributes to a family of neurodegenerative disorders in humans.

Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain
Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer's disease, Huntington's disease, epilepsy, stroke, dementia and malignant gliomas.

'Rotten eggs' in the blood
Hydrogen sulphide (H2S) is a gas most commonly associated with the smell of stink bombs, sewage and rotten eggs, but a team of researchers from the Peninsula Medical School in the South West of England and King's College London have now identified a role for this gas in regulating blood pressure, according to research published today in the leading science journal "Circulation".

Investigators unveil new drug discovery tool for Alzheimer's disease
An article published in the April issue of the Journal of Alzheimer's Disease presents a detailed characterization of a new drug discovery tool for Alzheimer's disease.

Redox-active iron is a sensor of cognitive impairment associated with Alzheimer's disease
An innovative discovery has been reported that highlights the problems that oxidative stress resulting from iron cumulated in the human brain can generate in relation with the pathogenesis of Alzheimer's disease (AD), the brain disorder affecting almost 30 million throughout the world.

Deadly genetic disease prevented before birth in zebrafish
By injecting a customized "genetic patch" into early stage fish embryos, researchers at Washington University School of Medicine in St. Louis were able to correct a genetic mutation so the embryos developed normally.

Promising new drug targets identified for Huntington's disease
Research funded by the Wellcome Trust has provided a number of promising new drug targets for Huntington's disease, a neurodegenerative disease. Scientists at the University of Cambridge have identified a number of candidate drugs to investigate further which encourage cells to "eat" the malformed proteins that lead to the disease.
More Neurodegeneration News Articles
Neuroacanthocytosis Syndromes II


Neurodegeneration in Multiple Sclerosis (Topics in Neuroscience)


Distinct patterns of olfactory impairment in Alzheimer's disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration [An article from: Neuropsychologia]
by S. Luzzi, J.S. Snowden, D. Neary, M. Coccia, Provi


Neuronal Death by Accident or by Design (Research and Perspectives in Neurosciences)


Metal-based Neurodegeneration: From Molecular Mechanisms to Therapeutic Strategies
by Robert Crichton, Roberta Ward


Neurons and astrocytes exhibit lower activities of global genome nucleotide excision repair than do fibroblasts [An article from: DNA Repair]
by A. Yamamoto, Y. Nakamura, N. Kobayashi, T Iwamoto


Bioimaging in Neurodegeneration (Contemporary Neuroscience)


Neuroprotection And Neurodegeneration in Parkinson's Disease (Round Table Series)
by Y. Mizuno


GLAUCOMA: AN OPEN-WINDOW TO NEURODEGENERATION AND NEUROPROTECTION, Volume 173 (Progress in Brain Research)


Neurodegeneration and Prion Disease
by David R. (EDT) Brown


© 2008 BrightSurf.com